Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

Ashina, M; Saper, J; Cady, R; Schaeffler, BA; Biondi, DM; Hirman, J; Pederson, S; Allan, B; Smith, J

Ashina, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.

CEPHALALGIA, 2020; 40 (3): 241

Abstract

Objective To evaluate the efficacy and safety of eptinezumab, a humanized anti-calcitonin gene-related peptide monoclonal antibody, in the preventive ......

Full Text Link